From Its Origins To Our Future
Biocodex is a family-owned multinational pharmaceutical company founded in France in 1953. The initial focus of the company was gastroenterology, featuring a unique probiotic: Saccharomyces boulardii CNCM I-745®, the first probiotic drug to have a positive effect on intestinal microbiota.
Biocodex History
The history of Biocodex started in 1923 with the discovery of the yeast Saccharomyces boulardii CNCM I-745® in Indochina by Henri Boulard. In 1953, Biocodex acquired the rights to Henri Boulard’s yeast strain and fermentation process launching the international pharmaceutical company.
Biocodex Vietnam today
Today, Biocodex has transformed itself, expanding its development around three pillars, microbiota, women’s heath, and orphan drugs. They are represented by 20 different subsidiaries across the globe and over 1,500 employees.
Asia is a key region for the Group, Vietnam is a fast-growing country, we have discovered our molecule in Vietnam, Biocodex Vietnam is the first affiliate of Biocodex Group in Asia.
VIETNAM Subsidiary has over 70 employees across three pillars, such as:
- Microbiota care as BIOFLORA® (Saccharomyces boulardii CNCM I-745®)
- Women Intimate Healthcare as SAFORELLE®
- Primary Care & Analgesia (PCA) as ACUPAN®, STRESAM®, STIMOL®, OTIPAX®, etc,…
